Our results are consistent with these studies since we observed higher frequencies of the TLR2 del allele in the CRC patients group compared with the control groups, highlighting the role of this polymorphism in colorectal carcinogenesis. This evidence concerns the gene TLR2 and colorectal carcinoma.